Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Müller C, Battiwalla M, Gajewski J, Verneris MR, Ringdén O, Marino S, Davies S, Dehn J, Bornhäuser M, Inamoto Y, Woolfrey A, Shaw P, Pollack M, Weisdorf D, Milller J, Hurley C, Lee SJ, Hsu K. Sobecks RM, et al. Among authors: pollack m. Biol Blood Marrow Transplant. 2015 Sep;21(9):1589-96. doi: 10.1016/j.bbmt.2015.05.002. Epub 2015 May 8. Biol Blood Marrow Transplant. 2015. PMID: 25960307 Free PMC article.
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.
Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos D, Waller EK, Spellman SR, Fernandez-Vina M, Ganser A, Aljurf M, Bornhaeuser M, Gupta V, Marino SR, Pollack MS, Reddy V, Eder M, Lee SJ. Dobbelstein C, et al. Among authors: pollack ms. Biol Blood Marrow Transplant. 2013 May;19(5):741-5. doi: 10.1016/j.bbmt.2013.01.020. Epub 2013 Feb 1. Biol Blood Marrow Transplant. 2013. PMID: 23380341 Free PMC article.
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR. Fleischhauer K, et al. Among authors: pollack ms. Bone Marrow Transplant. 2014 Sep;49(9):1176-83. doi: 10.1038/bmt.2014.122. Epub 2014 Jun 23. Bone Marrow Transplant. 2014. PMID: 24955785 Free PMC article.
Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.
Gupta V, Tomblyn M, Pedersen TL, Atkins HL, Battiwalla M, Gress RE, Pollack MS, Storek J, Thompson JC, Tiberghien P, Young JA, Ribaud P, Horowitz MM, Keating A. Gupta V, et al. Among authors: pollack ms. Biol Blood Marrow Transplant. 2009 Jul;15(7):864-71. doi: 10.1016/j.bbmt.2009.03.023. Biol Blood Marrow Transplant. 2009. PMID: 19539219 Free PMC article. Clinical Trial.
Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships.
Hurley CK, Setterholm M, Lau M, Pollack MS, Noreen H, Howard A, Fernandez-Vina M, Kukuruga D, Müller CR, Venance M, Wade JA, Oudshoorn M, Raffoux C, Enczmann J, Wernet P, Maiers M. Hurley CK, et al. Among authors: pollack ms. Bone Marrow Transplant. 2004 Feb;33(4):443-50. doi: 10.1038/sj.bmt.1704365. Bone Marrow Transplant. 2004. PMID: 14676778
Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.
Hachem RR, Kamoun M, Budev MM, Askar M, Ahya VN, Lee JC, Levine DJ, Pollack MS, Dhillon GS, Weill D, Schechtman KB, Leard LE, Golden JA, Baxter-Lowe L, Mohanakumar T, Tyan DB, Yusen RD. Hachem RR, et al. Among authors: pollack ms. Am J Transplant. 2018 Sep;18(9):2285-2294. doi: 10.1111/ajt.14893. Epub 2018 May 15. Am J Transplant. 2018. PMID: 29687961 Free PMC article.
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.
Shaughnessy PJ, Ornstein D, Ririe D, Callander N, Anderson JE, Pollack MS, Freytes CO, Cruz J, Rodriquez T, Bachier C, LeMaistre CF. Shaughnessy PJ, et al. Among authors: pollack ms. Biol Blood Marrow Transplant. 2002;8(8):420-8. doi: 10.1053/bbmt.2002.v8.pm12234167. Biol Blood Marrow Transplant. 2002. PMID: 12234167 Free article. Clinical Trial.
Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.
Shaughnessy P, Alexander W, Tran H, Ririe D, Splichal J, Pollack M, Bachier C, LeMaistre C. Shaughnessy P, et al. Among authors: pollack m. Mil Med. 2006 Feb;171(2):161-5. doi: 10.7205/milmed.171.2.161. Mil Med. 2006. PMID: 16578989 Clinical Trial.
1,208 results